COST-EFFECTIVENESS OF 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV) INCLUDING HERD PROTECTION IN TURKEY

被引：2
|
作者：
Turel, O. [1 ]
McIntosh, D.
Bakir, M. [1 ]
机构：
[1] Marmara Univ, Istanbul, Turkey
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66470-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A436 / A436
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants
    Perdrizet, Johnna
    Santana, Carlos Felipe S.
    Senna, Thais
    Alexandre, Rodrigo Fernandes
    de Almeida, Rodrigo Sini
    Spinardi, Julia
    Wasserman, Matt
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (04) : 1162 - 1172
  • [22] Compared effectiveness of the 7-valent pneumococcal conjugate vaccine in children with the 13-valent vaccine in adults
    Gaillat, J.
    MEDECINE ET MALADIES INFECTIEUSES, 2013, 43 (06): : 215 - 221
  • [23] Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens
    Mahon, BE
    Hsu, K
    Karumuri, S
    Kaplan, SL
    Mason, EO
    Pelton, SI
    VACCINE, 2006, 24 (14) : 2514 - 2520
  • [24] Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
    van Deursen, Anna M. M.
    van Mens, Suzan P.
    Sanders, Elisabeth A. M.
    Vlaminckx, Bart J. M.
    de Melker, Hester E.
    Schouls, Leo M.
    de Greeff, Sabine C.
    van der Ende, Arie
    EMERGING INFECTIOUS DISEASES, 2012, 18 (11) : 1729 - 1737
  • [25] The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine
    Silfverdal, Sven Arne
    Berg, Stefan
    Hemlin, Claes
    Jokinen, Iiro
    VACCINE, 2009, 27 (10) : 1601 - 1608
  • [26] The immunogenicity of 7-valent pneumococcal conjugate vaccine (PCV7) in adult bone marrow transplant patients
    MacIntyre, C. Raina
    Katelaris, Anthea L.
    Ridda, Iman
    Chughtai, Abrar A.
    Moa, Aye
    Barnes, Michelle
    Kabir, Masrura
    Bradstock, Kenneth
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (06) : 860 - 863
  • [27] The effect of the 7-valent conjugate vaccine (PCV7) on the incidence of pneumococcal infections world-wide
    Dobay, Orsolya
    Amyes, Sebastian G. B.
    Nagy, Karoly
    REVIEWS IN MEDICAL MICROBIOLOGY, 2008, 19 (03) : 79 - 85
  • [28] 13-Valent pneumococcal conjugate vaccine (PCV13) in children partially immunized with 7-valent pneumococcal conjugate vaccine (PCV7): A phase 3, open-label trial
    Silfverdal, Sven Arne
    Flodmark, Carl-Erik
    Rombo, Lars
    Tansey, Susan P.
    Sidhu, Mohinder
    Trammel, James
    Emini, Emilio A.
    Gruber, William C.
    Scott, Daniel A.
    Gurtman, Alejandra
    VACCINE, 2013, 31 (09) : 1284 - 1292
  • [29] Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV) Versus 10-Valent PCVs in Filipino Infants
    Perdrizet, J.
    Horn, E.
    Nua, W.
    Perez Peralta, J.
    Nailes, J.
    Santos, J.
    Ong-Lim, A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 : S118 - S118
  • [30] Immunogenicity and tolerance of a 7-valent pneumococcal conjugate vaccine in nonresponders to the 23-valent pneumococcal vaccine
    Zielen, S
    Bühring, I
    Strnad, N
    Reichenbach, J
    Hofmann, D
    INFECTION AND IMMUNITY, 2000, 68 (03) : 1435 - 1440
12345